Reuters logo
BRIEF-Chengdu Kanghong Pharmaceuticals Group biotechnology unit signs business contract
July 21, 2017 / 8:30 AM / 2 months ago

BRIEF-Chengdu Kanghong Pharmaceuticals Group biotechnology unit signs business contract

July 20(Reuters) - Chengdu Kanghong Pharmaceuticals Group Co Ltd

* Says its biotechnology unit signed a business contract in Beijing, with Ministry of Human Resources and Social Security social insurance management center, regarding injection for eyes use

* Says national insurance fund will pay 5,550 yuan for one injection, valid until Dec. 31, 2019

Source text in Chinese:goo.gl/YWK77b

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below